Dr.Sreedhar Jayakrishnan Cherulil

• Assistant Professor, Department of Medical Oncology - St Johan’s Medical College Hospital - Bengaluru, India - May 2025 -August 2026
• Consultant Physician - Modern Multispeciality Hospital, Kodungallur, Kerala, India - August 2021- April 2022
  • Served as an independent consultant Physician with responsibilities across inpatient, outpatient, and intensive care services.
  • Collaborated with peers and specialists to streamline ICU services and specialty care delivery.
  • Contributed to institutional safety and quality initiatives
• Senior Resident, Department of Endocrinology - Jawaharlal Nehru Medical College, Belagavi, India - May 2021 - July 2021 
  • Gained focused subspecialty in endocrinology after completion of training in general medicine 

• Medical Oncology
• Thoracic Oncology
• Immunotherapy
• Cellular Therapy
• Uro - Oncology
• Molecular Oncology
• Clinical Research
• Real - World Evidence
• AI in Oncology 
• Digital Oncology

Publications:

• cherulil SJ, Veetil GK, Chandrashekharan A, Payini Sk, Jayamohanan H. Functional and in silico stratification of TP53 mutations in non - small cell lung cancer. ESMO Open. 2026:11. Abstract 206P. doi:10.1016/j.esmoop.2026.108011.
• Cherulil SJ, Payini SK, Veetil GK, et al. Molecular profiling of metastic non-small cell lung carcinoma: Real- world analysis from a tertiary care centre in India. ESMO Open. 2025:10.
• Cherulil SJ, Veetil GK, PayiniSK, et al. Clinical feature- based mutation risk prediction in NSCLC using a GPT- derived model. ESMO Real World Data and Digital Oncology. 2025;10.
• Cheruili S, KV G, Kombath Payini S,et al. Molecular profile and disparity of care in metastatic non-small cell lung cancer in a low-middle income country: A retrospective analysis.
• Ch SK, KV G, Kombath Payini S, et al. Evaluating the real- world impact of atezolizumb and bevacizumab combination in unresectable hepatocellur carcinoma: A  South Indian experience.
• Safety and efficacy of generic propylene glycol- free melphalan as conditioning chemotherapy for autologous stem cell transplant in multiple myeloma. Presented at the 29th Annual Congress of the Asia-Pacific Blood and Marrow Transplantation Group
• The role of Brentuximab and Nivolumab in chemo-resistant mediastinal lymphoma prior to autologous stem cell transplant: A case report. Presented at the Educational Course of the Lymphoma Working Party of the EBNT,Warsaw, 2023 

Abstracts And Conference Publications: